BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Atacicept readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Atacicept\, from ClinicalTrials.gov estim
 ates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06983028-5425@assetmemo.bio
DTSTAMP:20261121T004058Z
DTSTART;VALUE=DATE:20271130
DTEND;VALUE=DATE:20271201
SUMMARY:Atacicept: Phase 2 readout est. (NCT06983028)
DESCRIPTION:Atacicept\, phase 2.\nStudy: Atacicept in Multiple Glomerular D
 iseases\nEstimated primary completion: November 2027. This is a ClinicalTr
 ials.gov estimate\, not a confirmed readout date\, and it can move.\nDrug 
 page: https://assetmemo.bio/drug/atacicept#upcoming-events\nRegistry recor
 d: https://clinicaltrials.gov/study/NCT06983028
URL:https://assetmemo.bio/drug/atacicept#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
BEGIN:VEVENT
UID:NCT06674577-5425@assetmemo.bio
DTSTAMP:20261121T004058Z
DTSTART;VALUE=DATE:20310521
DTEND;VALUE=DATE:20310522
SUMMARY:Atacicept: Phase 2 readout est. (NCT06674577)
DESCRIPTION:Atacicept\, phase 2\, IgA Nephropathy.\nStudy: A Rollover Study
  to Evaluate the Long-Term Safety and Efficacy of Atacicept\nEstimated pri
 mary completion: 21 May 2031. This is a ClinicalTrials.gov estimate\, not 
 a confirmed readout date\, and it can move.\nDrug page: https://assetmemo.
 bio/drug/atacicept#upcoming-events\nRegistry record: https://clinicaltrial
 s.gov/study/NCT06674577
URL:https://assetmemo.bio/drug/atacicept#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
